 
              Sanofi India Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q4 CY2021) - QoQ Comparison 
The company has reported total income of Rs.  704.2 crores during the period ended December 31, 2021 as compared to Rs. 769.2 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 90.4 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 529.8 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 39.25 for the period ended December 31, 2021 as compared to Rs. 230.04 for the period ended September 30, 2021.
                    
       | Total Income | ₹ 704.2 crs | ₹769.2  crs |  -8.45% | 
      | Net Profit | ₹90.4 crs | ₹529.8  crs |  -82.94% | 
      | EPS | ₹39.25 | ₹230.04 |  -82.94% | 
Financial Results  (Q4 CY2021) - YoY Comparison  The company has reported total income of Rs. 704.2 crores during the period ended December 31, 2021 as compared to Rs.736.5 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.90.4 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.123 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.39.25 for the period ended December 31, 2021 as compared to Rs.53.41 for the period ended December 31, 2020.
                    
      | Total Income | ₹ 704.2 crs | ₹736.5 crs |  -4.39% | 
      | Net Profit | ₹90.4  crs | ₹123 crs |  -26.50% | 
      | EPS | ₹39.25 | ₹53.41 |  -26.51% | 
 
Financial Results (Year Ended  CY2021) - YoY Comparison  The company has reported total income of Rs.3031 crores during the Calendar Year ended  December 31, 2021 as compared to Rs.2991.7 crores during the Calender Year ended  December 31, 2020.
The company has posted net profit / (loss) of Rs.944.4 crores for the Calendar Year ended  December 31, 2021 as against net profit / (loss) of Rs.477.6 crores for the Calender Year ended  December 31, 2020.
The company has reported EPS of Rs.410.06 for the Calendar Year ended  December 31, 2021 as compared to Rs.207.38 for the Calender Year ended  December 31, 2020.
                    
      | Total Income | ₹3031 crs | ₹2991.7 crs |  1.31% | 
      | Net Profit | ₹944.4 crs | ₹477.6 crs |  97.74% | 
      | EPS | ₹410.06 | ₹207.38 |  97.73% | 
Shares of Sanofi India Limited was last trading in BSE at Rs. 7277.45 as compared to the previous close of Rs. 7136.45. The total number of shares traded during the day was 728 in over 338 trades.
The stock hit an intraday high of Rs. 7302.00 and intraday low of 7172.60. The net turnover during the day was Rs. 5265238.00.
              
Source : Equity Bulls
              Keywords
                                       
                                               SanofiIndia 
                                               Q4CY21 
                                               CY2021 
                                               ResultUpdate